GCS1 anticorps (C-Term)

N° du produit ABIN5536221

Détail du produit anti-GCS1 anticorps

Antigène: GCS1 (MOGS) (Mannosyl-Oligosaccharide Glucosidase (MOGS))

Épitope: AA 796-826, C-Term

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp GCS1 est non-conjugé

Application: Western Blotting (WB)

Purification: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis

Immunogène: This GCS1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 796-826 amino acids from the C-terminal region of human GCS1.

Isotype: Ig Fraction

Information d'application

Indications d'application: For WB starting dilution is: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 2 mg/mL

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur GCS1

Antigène: GCS1 (MOGS) (Mannosyl-Oligosaccharide Glucosidase (MOGS))

Autre désignation: GCS1 (MOGS Produits)

Synonymes: anticorps Afu6g04210, anticorps AO090701000141, anticorps Mogs, anticorps CDG2B, anticorps CWH41, anticorps DER7, anticorps GCS1, anticorps 1810017N02Rik, anticorps AI181835, anticorps Gcs1, anticorps gcs1, anticorps im:7160827, anticorps wu:fe50a12, anticorps wu:fk09a10, anticorps zgc:158312, anticorps mannosyl-oligosaccharide glucosidase, anticorps mannosyl-oligosaccharide glucosidase GCS1, anticorps mannosyl-oligosaccharide glucosidase L homeolog, anticorps mannosyl oligosaccharide glucosidase, anticorps glucosidase 1, anticorps AFUA_6G04210, anticorps Tc00.1047053511015.10, anticorps Tc00.1047053511805.10, anticorps LOC5576381, anticorps AOR_1_260114, anticorps MGYG_00305, anticorps TERG_01248, anticorps mogs.L, anticorps TTHERM_00636930, anticorps LOAG_03690, anticorps Gcs1, anticorps MOGS, anticorps Mogs, anticorps mogs

Sujet: GCS1 cleaves the distal alpha 1,2-linked glucose residue from the Glc(3)Man(9)GlcNAc(2) oligosaccharide precursor in a highly specific manner. Defects in GCS1 are the cause of type IIb congenital disorder of glycosylation (CDGIIb). This syndrome is also known as glucosidase I deficiency and is characterized by marked generalized hypotonia and hypomotility of the neonate, dysmorphic features, including a prominent occiput, short palpebral fissures, retrognathia, high arched palate, generalized edema, and hypoplastic genitalia. Symptoms include hepatomegaly, hypoventilation, feeding problems and seizures. The clinical course is progressive and survival is at most a few months.

Poids moléculaire: 92 kDa

ID gène: 7841

UniProt: Q13724

Pathways: SARS-CoV-2 Protein Interactome